Comprehensive genomic diagnosis of non-syndromic and syndromic hereditary hearing loss in Spanish patients

[1]  H. Rehm,et al.  Exome sequencing in infants with congenital hearing impairment: a population-based cohort study , 2019, European Journal of Human Genetics.

[2]  B. Peterlin,et al.  Diagnostic outcomes of exome sequencing in patients with syndromic or non-syndromic hearing loss , 2018, PloS one.

[3]  W. Wuyts,et al.  Molecular diagnostics for hereditary hearing loss in children , 2017, Expert review of molecular diagnostics.

[4]  Marina N Nikiforova,et al.  Guidelines for Validation of Next-Generation Sequencing-Based Oncology Panels: A Joint Consensus Recommendation of the Association for Molecular Pathology and College of American Pathologists. , 2017, The Journal of molecular diagnostics : JMD.

[5]  G. R. Ordóñez,et al.  A novel molecular diagnostics platform for somatic and germline precision oncology , 2017, Molecular genetics & genomic medicine.

[6]  Christina M. Sloan,et al.  A novel mutation in ACTG1 causing Baraitser-Winter syndrome with extremely variable expressivity in three generations , 2017, Ophthalmic genetics.

[7]  Donna M. Muzny,et al.  Resolution of Disease Phenotypes Resulting from Multilocus Genomic Variation , 2017, The New England journal of medicine.

[8]  R. Pfundt,et al.  The diagnostic yield of whole-exome sequencing targeting a gene panel for hearing impairment in The Netherlands , 2016, European Journal of Human Genetics.

[9]  W. Chung,et al.  Recommendations for reporting of secondary findings in clinical exome and genome sequencing, 2016 update (ACMG SF v2.0): a policy statement of the American College of Medical Genetics and Genomics , 2016, Genetics in Medicine.

[10]  Gill Bejerano,et al.  M-CAP eliminates a majority of variants of uncertain significance in clinical exomes at high sensitivity , 2016, Nature Genetics.

[11]  Jason J. Corneveaux,et al.  DNA Diagnostics of Hereditary Hearing Loss: A Targeted Resequencing Approach Combined with a Mutation Classification System , 2016, Human mutation.

[12]  J. Sahel,et al.  An innovative strategy for the molecular diagnosis of Usher syndrome identifies causal biallelic mutations in 93% of European patients , 2016, European Journal of Human Genetics.

[13]  S. Bale,et al.  Whole exome sequencing reveals de novo pathogenic variants in KAT6A as a cause of a neurodevelopmental disorder , 2016, American journal of medical genetics. Part A.

[14]  Birgit Funke,et al.  Navigating highly homologous genes in a molecular diagnostic setting: a resource for clinical next-generation sequencing , 2016, Genetics in Medicine.

[15]  Raymond M. Moore,et al.  Evaluation of ACMG-Guideline-Based Variant Classification of Cancer Susceptibility and Non-Cancer-Associated Genes in Families Affected by Breast Cancer. , 2016, American journal of human genetics.

[16]  Shivang Doshi,et al.  Genomic Sequencing Procedure Microcosting Analysis and Health Economic Cost-Impact Analysis , 2016, The Journal of molecular diagnostics : JMD.

[17]  T. Lenarz,et al.  Prevalence and audiological profiles of GJB2 mutations in a large collective of hearing impaired patients , 2016, Hearing Research.

[18]  Xi Lin,et al.  Phenotypic Heterogeneity in a DFNA20/26 family segregating a novel ACTG1 mutation , 2016, BMC Genetics.

[19]  S. Nishio,et al.  Frequency of Usher syndrome type 1 in deaf children by massively parallel DNA sequencing , 2016, Journal of Human Genetics.

[20]  W. Chung,et al.  Clinical application of whole-exome sequencing across clinical indications , 2015, Genetics in Medicine.

[21]  Heidi L Rehm,et al.  Improving hearing loss gene testing: a systematic review of gene evidence toward more efficient next-generation sequencing–based diagnostic testing and interpretation , 2015, Genetics in Medicine.

[22]  Richard J. H. Smith,et al.  Massively Parallel Sequencing for Genetic Diagnosis of Hearing Loss , 2015, Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery.

[23]  M. Tekin,et al.  Comprehensive Analysis via Exome Sequencing Uncovers Genetic Etiology in Autosomal Recessive Non-Syndromic Deafness in a Large Multiethnic Cohort , 2015, Genetics in Medicine.

[24]  J. Clark,et al.  Congenital cytomegalovirus infection is a significant cause of moderate to profound sensorineural hearing loss in Queensland children , 2015, Journal of paediatrics and child health.

[25]  R. Gibbs,et al.  Comparison and integration of deleteriousness prediction methods for nonsynonymous SNVs in whole exome sequencing studies. , 2015, Human molecular genetics.

[26]  Bale,et al.  Standards and Guidelines for the Interpretation of Sequence Variants: A Joint Consensus Recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology , 2015, Genetics in Medicine.

[27]  A. Fulton,et al.  Panel-based Genetic Diagnostic Testing for Inherited Eye Diseases is Highly Accurate and Reproducible and More Sensitive for Variant Detection Than Exome Sequencing , 2014, Genetics in Medicine.

[28]  Sivakumar Gowrisankar,et al.  Comprehensive diagnostic testing for stereocilin: an approach for analyzing medically important genes with high homology. , 2014, The Journal of molecular diagnostics : JMD.

[29]  X. Liu,et al.  Whole-Exome Sequencing to Decipher the Genetic Heterogeneity of Hearing Loss in a Chinese Family with Deaf by Deaf Mating , 2014, PloS one.

[30]  Xuegong Zhang,et al.  Resolving the genetic heterogeneity of prelingual hearing loss within one family: Performance comparison and application of two targeted next generation sequencing approaches , 2014, Journal of Human Genetics.

[31]  Jianjun Wang,et al.  Combined examination of sequence and copy number variations in human deafness genes improves diagnosis for cases of genetic deafness , 2014, BMC Ear, Nose and Throat Disorders.

[32]  Tom R. Gaunt,et al.  Ranking non-synonymous single nucleotide polymorphisms based on disease concepts , 2014, Human Genomics.

[33]  Christina M. Sloan,et al.  Copy number variants are a common cause of non-syndromic hearing loss , 2014, Genome Medicine.

[34]  J. R. Holt,et al.  Sound Strategies for Hearing Restoration , 2014, Science.

[35]  Jana Marie Schwarz,et al.  MutationTaster2: mutation prediction for the deep-sequencing age , 2014, Nature Methods.

[36]  Heidi L Rehm,et al.  American College of Medical Genetics and Genomics guideline for the clinical evaluation and etiologic diagnosis of hearing loss , 2014, Genetics in Medicine.

[37]  D. Behar,et al.  The many faces of sensorineural hearing loss: one founder and two novel mutations affecting one family of mixed Jewish ancestry. , 2014, Genetic testing and molecular biomarkers.

[38]  D. Chan,et al.  GJB2‐associated hearing loss: Systematic review of worldwide prevalence, genotype, and auditory phenotype , 2014, The Laryngoscope.

[39]  K. Boycott,et al.  Rare-disease genetics in the era of next-generation sequencing: discovery to translation , 2013, Nature Reviews Genetics.

[40]  Adam P. DeLuca,et al.  Advancing genetic testing for deafness with genomic technology , 2013, Journal of Medical Genetics.

[41]  Heidi L. Rehm,et al.  Disease-targeted sequencing: a cornerstone in the clinic , 2013, Nature Reviews Genetics.

[42]  Xose S. Puente,et al.  Estimation of Copy Number Alterations from Exome Sequencing Data , 2012, PloS one.

[43]  X. Yi,et al.  Next-generation sequencing identifies a novel compound heterozygous mutation in MYO7A in a Chinese patient with Usher Syndrome 1B. , 2012, Clinica chimica acta; international journal of clinical chemistry.

[44]  J. Miller,et al.  Predicting the Functional Effect of Amino Acid Substitutions and Indels , 2012, PloS one.

[45]  Rubén Cabanillas Farpón,et al.  [Hereditary hearing loss: genetic counselling]. , 2012, Acta otorrinolaringologica espanola.

[46]  R. C. Farpón,et al.  [Hereditary hearing loss: genetic counselling]. , 2012, Acta otorrinolaringologica espanola.

[47]  Joseph T. Glessner,et al.  Genome‐wide SNP genotyping identifies the Stereocilin (STRC) gene as a major contributor to pediatric bilateral sensorineural hearing impairment , 2012, American journal of medical genetics. Part A.

[48]  D. Strachan,et al.  Hearing in 44–45 year olds with m.1555A>G, a genetic mutation predisposing to aminoglycoside-induced deafness: a population based cohort study , 2012, BMJ Open.

[49]  Juliane C. Dohm,et al.  Whole-genome sequencing identifies recurrent mutations in chronic lymphocytic leukaemia , 2011, Nature.

[50]  C. Sander,et al.  Predicting the functional impact of protein mutations: application to cancer genomics , 2011, Nucleic acids research.

[51]  Adam P. DeLuca,et al.  DFNA8/12 caused by TECTA mutations is the most identified subtype of nonsyndromic autosomal dominant hearing loss , 2011, Human mutation.

[52]  Serafim Batzoglou,et al.  Identifying a High Fraction of the Human Genome to be under Selective Constraint Using GERP++ , 2010, PLoS Comput. Biol..

[53]  P. Bork,et al.  A method and server for predicting damaging missense mutations , 2010, Nature Methods.

[54]  Richard Durbin,et al.  Fast and accurate long-read alignment with Burrows–Wheeler transform , 2010, Bioinform..

[55]  Justin C. Fay,et al.  Identification of deleterious mutations within three human genomes. , 2009, Genome research.

[56]  R. Goodyear,et al.  In vivo and in vitro effects of two novel gamma-actin (ACTG1) mutations that cause DFNA20/26 hearing impairment. , 2009, Human molecular genetics.

[57]  Gonçalo R. Abecasis,et al.  The Sequence Alignment/Map format and SAMtools , 2009, Bioinform..

[58]  Richard Durbin,et al.  Sequence analysis Fast and accurate short read alignment with Burrows – Wheeler transform , 2009 .

[59]  Richard J. H. Smith,et al.  Forty-six genes causing nonsyndromic hearing impairment: which ones should be analyzed in DNA diagnostics? , 2009, Mutation research.

[60]  F. Moreno,et al.  Q829X, a novel mutation in the gene encoding otoferlin (OTOF), is frequently found in Spanish patients with prelingual non-syndromic hearing loss , 2002, Journal of medical genetics.

[61]  A. Kenneson,et al.  GJB2 (connexin 26) variants and nonsyndromic sensorineural hearing loss: A HuGE review , 2002, Genetics in Medicine.

[62]  X. Estivill,et al.  Connexin-26 mutations in sporadic and inherited sensorineural deafness , 1998, The Lancet.

[63]  W. Reardon,et al.  Pendred syndrome--100 years of underascertainment? , 1997, QJM : monthly journal of the Association of Physicians.

[64]  Faustino Núñez-Batalla,et al.  Aetiological diagnosis of child deafness: CODEPEH recommendations. , 2017, Acta otorrinolaringologica espanola.

[65]  Faustino Núñez-Batalla,et al.  Aetiological diagnosis of child deafness: CODEPEH recommendations , 2017 .

[66]  Faustino Núñez-Batalla,et al.  Aetiological Diagnosis of Child Deafness : CODEPEH Recommendations , 2019 .

[67]  R. Cabanillas Farpón,et al.  [Hereditary hearing loss: genetic counselling]. , 2012, Acta Otorrinolaringológica Española.

[68]  S. Henikoff,et al.  Predicting the effects of coding non-synonymous variants on protein function using the SIFT algorithm , 2009, Nature Protocols.

[69]  F. Moreno,et al.  [Prevalence of the 35delG mutation in the GJB2 gene, del (GJB6-D13S1830) in the GJB6 gene, Q829X in the OTOF gene and A1555G in the mitochondrial 12S rRNA gene in subjects with non-syndromic sensorineural hearing impairment of congenital/childhood onset]. , 2005, Acta otorrinolaringologica espanola.

[70]  X. Estivill,et al.  High carrier frequency of the 35delG deafness mutation in European populations , 2000, European Journal of Human Genetics.